<?xml version='1.0' encoding='UTF-8' standalone='no'?>
<rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:bqbiol="http://biomodels.net/biology-qualifiers/" xmlns:collex="http://www.collex.org/schema#" xmlns:bqmodel="http://biomodels.net/model-qualifiers/" xmlns:scoro="http://purl.org/spar/scoro/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:biomodel="http://biomodels.net/model-qualifiers/">
  <rdf:Description rdf:about="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex">
    <dc:title>Swanson, True, Lin, Buhler, Vessella, Murray, 2001</dc:title>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex">
    <prism:keyword>cancer</prism:keyword>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex">
    <prism:keyword>T lymphocytes</prism:keyword>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex">
    <prism:keyword>immunology</prism:keyword>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex">
    <prism:keyword>t lymphocytes</prism:keyword>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex">
    <dc:description>

#### Model Status


This CellML model runs in both OpenCell and COR, the units are consistent and parameter values for constants have been set to LuCaP23.1 from table 1. The general shape of the simulation output seems correct (figure 1), however the scale is not the same as the figure in the published paper.


#### Model Structure


ABSTRACT: Prostate-specific antigen (PSA) is an enzyme produced by both normal and cancerous prostate epithelial cells. Although PSA is the most widely used serum marker to detect and follow patients with prostatic adenocarcinoma, there are certain anomalies in the values of serum levels of PSA that are not understood. We developed a mathematical model for the dynamics of serum levels of PSA as a function of the tumor volume. Our model results show good agreement with experimental observations and provide an explanation for the existence of significant prostatic tumor mass despite a low-serum PSA. This result can be very useful in enhancing the use of serum PSA levels as a marker for cancer growth.


The original paper is cited below:


A Quantitative Model for the Dynamics of Serum Prostate-Specific Antigen as a Marker for Cancerous Growth, Kristin R. Swanson, Lawrence D. True, Daniel W. Lin, Kent R. Buhler, Robert Vessella, and James D. Murray, 2001, *American Journal of Pathology*, 158, 2195-2199. [PubMed ID: 11395397](http://www.ncbi.nlm.nih.gov/pubmed/11395397)



</dc:description>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex">
    <collex:thumbnail rdf:resource="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex/swanson_2001.png">http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex/swanson_2001.png</collex:thumbnail>
  </rdf:Description>
  <rdf:Description rdf:about="local:00001">
    <rdfs:label>Kristin R. Swanson</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="local:00001">
    <foaf:name>Kristin R. Swanson</foaf:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex">
    <dc:creator rdf:resource="local:00001">local:00001</dc:creator>
  </rdf:Description>
  <rdf:Description rdf:about="local:00002">
    <rdfs:label>Lawrence D. True</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="local:00002">
    <foaf:name>Lawrence D. True</foaf:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex">
    <dc:creator rdf:resource="local:00002">local:00002</dc:creator>
  </rdf:Description>
  <rdf:Description rdf:about="local:00003">
    <rdfs:label>Daniel W. Lin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="local:00003">
    <foaf:name>Daniel W. Lin</foaf:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex">
    <dc:creator rdf:resource="local:00003">local:00003</dc:creator>
  </rdf:Description>
  <rdf:Description rdf:about="local:00004">
    <rdfs:label>Kent R. Buhler</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="local:00004">
    <foaf:name>Kent R. Buhler</foaf:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex">
    <dc:creator rdf:resource="local:00004">local:00004</dc:creator>
  </rdf:Description>
  <rdf:Description rdf:about="local:00005">
    <rdfs:label>Robert Vessella</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="local:00005">
    <foaf:name>Robert Vessella</foaf:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex">
    <dc:creator rdf:resource="local:00005">local:00005</dc:creator>
  </rdf:Description>
  <rdf:Description rdf:about="local:00006">
    <rdfs:label>James D. Murray</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="local:00006">
    <foaf:name>James D. Murray</foaf:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex">
    <dc:creator rdf:resource="local:00006">local:00006</dc:creator>
  </rdf:Description>
  <rdf:Description rdf:about="local:00007">
    <dc:identifier rdf:resource="http://identifiers.org/orcid:0000-0001-5801-5510">http://identifiers.org/orcid:0000-0001-5801-5510</dc:identifier>
  </rdf:Description>
  <rdf:Description rdf:about="local:00007">
    <rdfs:label>Bilal Shaikh</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="local:00007">
    <foaf:accountName rdf:resource="https://orcid.org/0000-0001-5801-5510">https://orcid.org/0000-0001-5801-5510</foaf:accountName>
  </rdf:Description>
  <rdf:Description rdf:about="local:00007">
    <foaf:name>Bilal Shaikh</foaf:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex">
    <dc:contributor rdf:resource="local:00007">local:00007</dc:contributor>
  </rdf:Description>
  <rdf:Description rdf:about="local:00008">
    <rdfs:label>Catherine Lloyd</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="local:00008">
    <foaf:name>Catherine Lloyd</foaf:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex">
    <dc:contributor rdf:resource="local:00008">local:00008</dc:contributor>
  </rdf:Description>
  <rdf:Description rdf:about="local:00009">
    <dc:identifier rdf:resource="https://identifiers.org/pmr:44af0d12c96f6486871eb3d81ba4e0a6">https://identifiers.org/pmr:44af0d12c96f6486871eb3d81ba4e0a6</dc:identifier>
  </rdf:Description>
  <rdf:Description rdf:about="local:00009">
    <rdfs:label>PMR: 44af0d12c96f6486871eb3d81ba4e0a6</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex">
    <bqmodel:is rdf:resource="local:00009">local:00009</bqmodel:is>
  </rdf:Description>
  <rdf:Description rdf:about="local:00010">
    <dc:identifier rdf:resource="https://identifiers.org/doi/10.1016/S0002-9440(10)64691-3">https://identifiers.org/doi/10.1016/S0002-9440(10)64691-3</dc:identifier>
  </rdf:Description>
  <rdf:Description rdf:about="local:00010">
    <rdfs:label>Kristin R. Swanson, Lawrence D. True, Daniel W. Lin, Kent R. Buhler, Robert Vessella &amp; James D. Murray. A quantitative model for the dynamics of serum prostate-specific antigen as a marker for cancerous growth: an explanation for a medical anomaly. The American Journal of Pathology 158, 6: 2195-2199 (2001).</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex">
    <bqmodel:isDescribedBy rdf:resource="local:00010">local:00010</bqmodel:isDescribedBy>
  </rdf:Description>
  <rdf:Description rdf:about="local:00011">
    <dc:identifier rdf:resource="https://creativecommons.org/licenses/by/3.0/">https://creativecommons.org/licenses/by/3.0/</dc:identifier>
  </rdf:Description>
  <rdf:Description rdf:about="local:00011">
    <rdfs:label>CC BY 3.0</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex">
    <dc:license rdf:resource="local:00011">local:00011</dc:license>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex/swanson_true_lin_buhler_vessella_murray_2001.cellml">
    <dc:title>A Quantitative Model for the Dynamics of Serum Prostate-Specific Antigen as a Marker for Cancerous Growth</dc:title>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex/swanson_true_lin_buhler_vessella_murray_2001.cellml">
    <dc:description>

#### Model Status


This CellML model runs in both OpenCell and COR, the units are consistent and parameter values for constants have been set to LuCaP23.1 from table 1. The general shape of the simulation output seems correct (figure 1), however the scale is not the same as the figure in the published paper.


#### Model Structure


ABSTRACT: Prostate-specific antigen (PSA) is an enzyme produced by both normal and cancerous prostate epithelial cells. Although PSA is the most widely used serum marker to detect and follow patients with prostatic adenocarcinoma, there are certain anomalies in the values of serum levels of PSA that are not understood. We developed a mathematical model for the dynamics of serum levels of PSA as a function of the tumor volume. Our model results show good agreement with experimental observations and provide an explanation for the existence of significant prostatic tumor mass despite a low-serum PSA. This result can be very useful in enhancing the use of serum PSA levels as a marker for cancer growth.


The original paper is cited below:


A Quantitative Model for the Dynamics of Serum Prostate-Specific Antigen as a Marker for Cancerous Growth, Kristin R. Swanson, Lawrence D. True, Daniel W. Lin, Kent R. Buhler, Robert Vessella, and James D. Murray, 2001, *American Journal of Pathology*, 158, 2195-2199. [PubMed ID: 11395397](http://www.ncbi.nlm.nih.gov/pubmed/11395397)




</dc:description>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex/swanson_true_lin_buhler_vessella_murray_2001.cellml">
    <collex:thumbnail rdf:resource="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex/swanson_2001.png">http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex/swanson_2001.png</collex:thumbnail>
  </rdf:Description>
  <rdf:Description rdf:about="local:00012">
    <dc:identifier rdf:resource="https://creativecommons.org/licenses/by/3.0/">https://creativecommons.org/licenses/by/3.0/</dc:identifier>
  </rdf:Description>
  <rdf:Description rdf:about="local:00012">
    <rdfs:label>CC BY 3.0</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/44af0d12c96f6486871eb3d81ba4e0a6.omex/swanson_true_lin_buhler_vessella_murray_2001.cellml">
    <dc:license rdf:resource="local:00012">local:00012</dc:license>
  </rdf:Description>
</rdf:RDF>
